Ligand-Mimetic Activating Antibody Preparation Service

Cell-surface receptors are switched on when their natural ligand binds, and the same effect can sometimes be achieved by an antibody that attaches to the receptor in the right place, in the right way. Such an antibody is called ligand-mimetic or agonistic: instead of blocking a pathway, it activates it, standing in for the ligand that would normally do the job. This makes activating antibodies valuable tools for studying signaling and for exploring receptor-directed approaches.

Finding an agonist is harder than finding a binder, because the antibody must not only attach to the receptor but also induce the change that starts signaling. A candidate that binds strongly can still be an inert binder or even a blocker. Screening therefore has to test function — receptor activation — rather than binding alone, and the generation route must be capable of producing antibodies that engage the relevant part of the receptor.

We prepare ligand-mimetic activating antibodies with functional screening built into the workflow, so candidates are judged by whether they activate the receptor and not merely by how tightly they bind.

What the Service Covers

• Hybridoma-based generation – producing monoclonal candidates by classical immunization and screening against the receptor.
• Display-based selection – using antibody display libraries, including immune libraries built for the target, to select binders against the receptor's ligand-binding region.
• Functional screening for activation – testing candidates for receptor activation so that agonist behavior, not binding, decides selection.
• Negative screening – excluding candidates that bind without activating, or that block the receptor instead of triggering it.

Why Activation Is Harder Than Binding

The properties that make a good binder and a good agonist are not the same.

Workflow

• Define the target and readout – agree the receptor and the functional readout that will count as activation.
• Choose the generation route – select hybridoma or display-based selection according to the target and available libraries.
• Generate candidates – produce a panel directed at the receptor's ligand-binding region.
• Screen for function – test candidates for receptor activation and set aside non-activating binders.
• Deliver – supply the activating antibody with the functional data that demonstrate its behavior.

Applications

• Signaling studies – activating a pathway deliberately in order to study its downstream effects.
• Receptor biology – probing how a receptor responds when engaged at a defined site.
• Functional tool reagents – antibodies that can switch a receptor on as an alternative to its natural ligand.
• Early research prototypes – agonist candidates explored as starting points for receptor-directed development.

Why Work With Us

Agonist antibodies are found by testing function, so we put functional screening at the center of the project instead of treating it as a final check. We select a generation route capable of engaging the receptor's active region, screen candidates for activation rather than binding, and are clear when a candidate binds but does not activate, so the results reflect what the antibody actually does.